Seller record · Telehealth service

Metabolyz

By Peptide Alliance, Editorial publisherRecorded October 2026 · Standard v1.1 · How checks are performed

Fails 2 of 8 criteria. S3, pharmacy identification: No filling pharmacy is named. The pages refer only to partner compounding pharmacies and licensed 503A and 503B US pharmacies. 1 more criterion also fails; see the table below.

At a glance

MetabolyzTelehealth service

6/8criteria passed

Price: Compounded semaglutide from $149 a month, a GLP-1 microdose from $99 a month and tirzepatide from $175 a month
Sells: compounded semaglutide, compounded tirzepatide, GLP-1 microdose, and 2 more
FDA letters: None on file

Visit Metabolyz See all eight dispositions

Telehealth service. Passes 6 of 8 criteria. Recorded against Standard v1.1.

A San Diego telehealth platform pairing compounded semaglutide, tirzepatide and microdose GLP-1 programs with nutrition and lifestyle coaching, alongside compounded tesamorelin and NAD+, prescribed by independent licensed providers.

Operating entity The Westview Drive Co Inc

Dispositions

Code	Criterion	Disposition	Where it appears
S1	Prescriber requirement	PASS	Metabolyz's website; Metabolyz's semaglutide product page
S2	Prescription gating	PASS	Metabolyz's peptides page; Metabolyz's website
S3	Pharmacy identification	FAIL	Metabolyz's semaglutide product page; Metabolyz's website
S4	Compounding disclosure	PASS	Metabolyz's website; Metabolyz's peptides page; Metabolyz's tesamorelin product page
S5	Analytical documentation	FAIL	Metabolyz's semaglutide product page; Metabolyz's peptides page; Metabolyz's terms
S6	Business address	PASS	Metabolyz's contact page; Metabolyz's terms; Metabolyz's privacy page
S7	Price disclosure	PASS	Metabolyz's peptides page; Metabolyz's semaglutide product page
S8	Enforcement status	PASS	FDA warning-letter index

Evidence, criterion by criterion

The evidence behind each disposition in the table above, where it appears, and its date.

S1PASSA licensed clinician reviews each consultation and medical history before authorizing treatment, and the disclaimer says all evaluations and prescribing decisions are made by independent, board-certified US providers.Source: Metabolyz's website; Metabolyz's semaglutide product page.

S2PASSThe steps list a short assessment first and a licensed provider's review second, and the footer says treatment charges are not processed for a patient who is not medically approved.Source: Metabolyz's peptides page; Metabolyz's website.

S3FAILNo filling pharmacy is named. The pages refer only to partner compounding pharmacies and licensed 503A and 503B US pharmacies.Source: Metabolyz's semaglutide product page; Metabolyz's website.

S4PASSThe footer of every page states that compounded medications are not FDA-approved, and the program and peptide pages describe the semaglutide, tirzepatide, tesamorelin and NAD+ as compounded.Source: Metabolyz's website; Metabolyz's peptides page; Metabolyz's tesamorelin product page.

S5FAILNo certificate of analysis or lot document is published on the program pages, the peptide pages or the terms.Source: Metabolyz's semaglutide product page; Metabolyz's peptides page; Metabolyz's terms.

S6PASSThe Westview Drive Co Inc at 401 B Street, Suite 1900, San Diego, CA 92101, printed as the clinic address on the contact page and as the mailing address in the terms and privacy policy. The terms name Delaware law.Source: Metabolyz's contact page; Metabolyz's terms; Metabolyz's privacy page.

S7PASSThe peptide catalog prints compounded semaglutide from $149 a month, a GLP-1 microdose from $99 a month, tirzepatide from $175 a month, tesamorelin from $249 a month and NAD+ from $169 a month. The answers on the weight program pages say instead that pricing is reviewed during the consultation and not published on public pages.Source: Metabolyz's peptides page; Metabolyz's semaglutide product page.

S8PASSNo FDA warning letter names Metabolyz or The Westview Drive Co Inc, and no action has halted the business.Source: FDA warning-letter index.

Products shown on the seller's own pages at the recorded date: compounded semaglutide, compounded tirzepatide, GLP-1 microdose, tesamorelin, NAD+.

Other sellers of the same products

Who sells semaglutide Who sells tirzepatide Who sells NAD+Who sells tesamorelin

Visit Metabolyz

Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.